AllSight
Companies · SRZN · Biological Products, (No Diagnostic Substances)
Surrozen, Inc./DE (SRZN)
Surrozen, Inc./DE (SRZN) stock — the fundamentals (P/E, market cap, valuation) and every material event, decoded in plain English.
Oct 2, 2026$95.1M financing unlocked
Surrozen FDA clearance unlocks $95.1M financing, but dilution follows
Related companies in Biological Products, (No Diagnostic Substances)
About AllSight · Editorial standards & method · Contact